Journal
CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume 107, Issue 4, Pages 697-699Publisher
WILEY
DOI: 10.1002/cpt.1792
Keywords
-
Categories
Ask authors/readers for more resources
Over the past quarter century, artificial intelligence/machine learning (AI/ML) enthusiasts have repeatedly promised to revolutionize predictive analytics in clinical pharmacology (CP) but have fallen short. With new digital and omics data types yielding increased data volume and complexity, and widespread acceptance of AI/ML across industries, has CP finally reached its John Henry Moment? Will the foundational work of CP be swept away by AI/ML-based predictive analytics, or does our AI/ML experience to date suggest a more optimistic fate?
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available